| Clinical Trial Name | Clinical Trial Full Title | Principal Investigator | Project site status | Clinical trials gov number |
|---|---|---|---|---|
| (AstraZeneca) D0816L00003 / LIGHT | Non-Randomized, Open-Label Phase II Study to Assess Olaparib Tablets as a Treatment for Subjects with Different HRD Tumor Status and with Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer That Have Received at Least 2 Prior Lines of Chemotherapy | Helpman, Dr Limor | Open | NCT02983799 |
| (UHN) NECO / NEC | A Phase II, Open label Study of the Poly(ADP-ribose) Polymerase Inhibitor Niraparib (MK 4827) in Recurrent Endometrial Cancer | Jimenez, Dr Waldo | Open | NCT03016338 |
| (UHN) PHL-086 | A Phase 2 Study of XL184 (Cabozantinib) in Recurrent or Metastatic Endometrial Cancer | Hirte, Dr Hal | On hold | NCT01815151 |
Find a Trial
Contact Us